Nitric oxide (NO) and cartilage metabolism: NO effects are modulated by superoxide in response to IL-1

Biorheology

Volumn 39, Issue 1-2, 2002, Pages 201-214

  Jouzeau, Jean Yves ^a   Pacquelet, Sandrine ^a   Boileau, Christelle ^a   Nedelec, Emmanuelle ^a   Presle, Nathalie ^a   Netter, Patrick ^a   Terlain, Bernard ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

Author keywords

Chondrocytes; Interleukin 1; Nitric oxide; NO synthase inhibitors; Proteoglycans; Superoxide

Indexed keywords

3 NITROTYROSINE; ANTIOXIDANT; COPPER (3,5 DIISOPROPYLSALICYLATE) 2; COPPER DERIVATIVE; CYCLOOXYGENASE 2; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 17; INTERLEUKIN 1BETA; N(G) METHYL DEXTRO ARGININE; N(G) METHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; OXYGEN; PEROXYNITRITE; PROTEOGLYCAN; REACTIVE OXYGEN METABOLITE; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTHROPATHY; CARTILAGE; CARTILAGE CELL; CARTILAGE MATRIX; CELL RENEWAL; CELL STIMULATION; CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVITY; FEMUR CONDYLE; MALE; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN SYNTHESIS; PROTEIN SYNTHESIS INHIBITION; RAT; TISSUE METABOLISM;

ANIMALS; CARTILAGE DISEASES; CARTILAGE, ARTICULAR; CELLS, CULTURED; CHONDROCYTES; DEPRESSION, CHEMICAL; ENZYME INHIBITORS; FREE RADICAL SCAVENGERS; HUMANS; INTERLEUKIN-1; INTERLEUKIN-17; MALE; MODELS, ANIMAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OMEGA-N-METHYLARGININE; PROTEOGLYCANS; RATS; RATS, WISTAR; SALICYLIC ACIDS;

EID: 0036286386     PISSN: 0006355X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (56)

1. The expression and regulation of nitric oxide synthase in human osteoarthritis-affected chondrocytes: Evidence for up-regulated neuronal nitric oxide synthase
2. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis
3. Inhibition of proteoglycan synthesis by hydrogen peroxide in cultured bovine articular cartilage
4. Nitric oxide, superoxide, and peroxynitrite: The good, the bad, and ugly
5. Chondrocyte apoptosis induced by nitric oxide
6. Nitric oxide and the regulation of gene expression
7. Hydrogen peroxide and the proliferation of BHK-21 cells
8. Nitric oxide production during adjuvant-induced and collagen-induced arthritis
9. Chondroprotective effect of intraarticular injections of interleukin-1 receptor antagonist in experimental osteoarthritis
10. Modulation of IL-1-induced cartilage injury by NO synthase inhibitors: A comparative study with rat chondrocytes and cartilage entities
11. Antioxidant therapy: A new pharmacological approach in shock, inflammation, and ischemia/reperfusion injury
12. Nitric oxide and G proteins mediate the response of bovine articular chondrocytes to fluid-induced shear
13. Nitric oxide and cartilage metabolism
14. Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases
15. Therapeutic administration of a selective inhibitor of nitric oxide synthase does not ameliorate the chronic inflammation and tissue damage associated with adjuvant-induced arthritis in rats
16. What nitrates tyrosine? Is nitrotyrosine specific as a biomarker of peroxynitrite formation in vivo?
17. Nitric oxide and proteoglycan biosynthesis by human articular chondrocytes in alginate cultures
18. Detection of superoxide and NADPH oxidase in porcine articular chondrocytes
19. Nitric oxide in arthritis
20. Peroxynitrite, the coupling product of nitric oxide and superoxide activates prostaglandin biosynthesis
21. The influence of mechanical loading on isolated chondrocytes seeded in agarose constructs
22. Injurious mechanical compression of bovine articular cartilage induces chondrocyte apoptosis
23. Comparison of the peroxidase reaction kinetics of prostaglandin H synthase-1 and -2
24. Reduction of interleukin-17-induced inhibition of chondrocyte proteoglycan synthesis in intact murine articular cartilage by interleukin-4
25. Nitric oxide synthase inhibitor influences prostaglandin and interleukin-1 production in experimental arthritic joints
26. Detection of protein and mRNA of various components of the NADPH oxidase complex in an immortalized human chondrocyte line
27. Effect of liposomal-encapsulated superoxide dismutase on active oxygen-related human disorders. A preliminary study
28. Concurrent generation of nitric oxide and superoxide inhibits proteoglycan synthesis in bovine articular cartilage: Involvement of peroxynitrite
29. Induction of nitric oxide synthase in human chondrocytes
30. Effect of reactive oxygen species on the biosynthesis and structure of newly synthesized proteoglycans
31. Cytokines and inflammation in cartilage degradation
32. In vivo suppression of early experimental osteoarthritis by interleukin-1 receptor antagonist using gene therapy
33. Reduced progression of experimental osteoarthritis in vivo by selective inhibition of nitric oxide synthase
34. Selective inhibition of inducible nitric oxide synthase in experimental osteoarthritis is associated with reduction in tissue levels of catabolic factors
35. The non specificity of specific nitric oxide synthase inhibitors
36. Dityrosine formation outcompetes tyrosine nitration at low steady-state concentrations of peroxynitrite
37. Mechanism of superoxide generation by neuronal nitric-oxide synthase
38. Cartilage protection by nitric oxide synthase inhibitors after intraarticular injection of interleukin-1β in rat
39. Unraveling peroxynitrite formation in biological systems
40. Lucigenin-dependent chemiluminescence in articular chondrocytes
41. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides
42. Interactions of nitric oxide with cylooxygenases: In vitro, ex vivo, and in vivo studies
43. Tyrosine nitration by peroxynitrite formed from nitric oxide and superoxide generated by xanthine oxydase
44. Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-κB
45. Selective pharmacological inhibition of distinct nitric oxide synthase isoforms
46. Articular chondrocytes synthesize nitric oxide in response to cytokines and lipopolysaccharide
47. N-monomethyl arginine, an inhibitor of nitric oxide synthase, suppresses the development of adjuvant arthritis in rats
48. Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis
49. The role of nitric oxide in proteoglycan turnover by bovine articular cartilage organ cultures
50. Inhibition of transforming growth factor β production by nitric oxide-treated chondrocytes. Implications for matrix synthesis
51. Production of hydrogen peroxide by rabbit articular chondrocytes. Enhancement by cytokines
52. Hydroxyl radical formation in chondrocytes and cartilage as detected by electron paramagnetic resonance spectroscopy using spin trapping reagents
53. Protection against cartilage proteoglycan synthesis inhibition by antiinterleukin 1 antibodies in experimental arthritis
54. Reduced cartilage proteoglycan loss during zymosan-induced gonarthritis in NOS2-deficient mice and in anti-interleukin-1-treated wild-type mice with unabated joint inflammation
55. Antioxidant treatment induces transcription and expression of transforming growth factor β in cultured renal proximal tubular cells
56. Comparison of antioxidant activities of aminoguanidine, methylguanidine and guanidine by luminol-enhanced chemiluminescence